147 results
8-K
EX-4.2
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company … sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any
8-K
EX-4.1
HEPA
Hepion Pharmaceuticals Inc
16 Feb 24
Entry into a Material Definitive Agreement
9:02am
share.
-4-
vi. Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax … to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice
8-K
EX-4.2
d41basifw6eh1c1
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-10.1
pjwhvb30ei
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.1
2hy4io8 uuoddb3yj1
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
8-K
EX-4.3
5zys vp7p7
2 Oct 23
Hepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
6:29pm
424B5
vzys0a4bugo o6haxd
2 Oct 23
Prospectus supplement for primary offering
4:52pm
8-K
EX-1.1
an77hga1w o0dkcvnh
21 Jul 23
Entry into a Material Definitive Agreement
4:41pm
424B5
n04qas24o45u8qgiqu9p
21 Jul 23
Prospectus supplement for primary offering
4:39pm